The Notch signaling pathway in skeletal muscle health and disease

August 12, 2022. Muscle and Nerve, 66(5), 530-544. https://doi.org/10.1002/mus.27684

D. Vargas-Franco, R. Kalra, I. Draper, C.A. Pacak, A. Asakura, P.B. Kang

Selective serotonin reuptake inhibitors ameliorate MEGF10 myopathy

July 15, 2019. Human molecular genetics, 28(14), 2365-2377. https://doi.org/10.1093/hmg/ddz064

M. Saha, S.A. Rizzo, M. Ramanathan, R.M. Hightower, K.E. Santostefano, N. Terada, R.S. Finkel, J.S. Berg, N. Chahin, C.A. Pacak, R.E. Wagner, M.S. Alexander, I. Draper, P.B. Kang

The impact of Megf10/Drpr gain-of-function on muscle development in Drosophila

February 25, 2019. FEBS Letters, 593(7), 680-696. https://doi.org/10.1002/1873-3468.13348

I. Draper, M. Saha, H. Stonebreaker, R.N. Salomon, B. Matin, P.B. Kang

Consequences of MEGF10 deficiency on myoblast function and Notch1 interactions

August 1, 2017. Human molecular genetics, 26(15), 2984-3000. https://doi.org/10.1093/hmg/ddx189

M. Saha, S. Mitsuhashi, M.D. Jones, K. Manko, H.M. Reddy, C.C. Bruels, K.A. Cho, C.A. Pacak, I. Draper, P.B. Kang

Silencing of drpr leads to muscle and brain degeneration in adult Drosophila

October 2014. American Journal of Pathology, 184(10), 2653-2661. https://doi.org/10.1016/j.ajpath.2014.06.018

I. Draper, L.J. Mahoney, S. Mitsuhashi, C.A. Pacak, R.N. Salomon, P.B. Kang

Cysteine mutations cause defective tyrosine phosphorylation in MEGF10 myopathy

September 17, 2013. FEBS Letters, 587(18), 2952-2957. https://doi.org/10.1016/j.febslet.2013.08.002

S. Mitsuhashi, H. Mitsuhashi, M.S. Alexander, H. Sugimoto, P.B. Kang